Exact FDA event identifier

Event 77427

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket: June 01, 2017
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: Lucid Pharma LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.

D-0921-2017

Recall number: D-0921-2017
Initiated: June 01, 2017
Classification: Class II
Status: Terminated
Recalling firm: Lucid Pharma LLC
Quantity: a) 44168 bottles; b) 24960 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0

Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.

Code information

Lot #: a) V17516045-A, Exp 08/18; b) V17516047-A 09/18

Distribution pattern

Nationwide in the USA